Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 5Phase 1 2Phase 4 1

Status

Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 10Gynecologic 7Breast 5Dermatologic 2Gastrointestinal 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Primary Breast Cancer 1

Interventions

Cyclophosphamide 171Docetaxel 164Paclitaxel 160Trastuzumab 152Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × CP protocol × Breast × Clear all
NCT03168880 2025-04-09

TNBC

Tata Memorial Hospital

Phase 3 Active not recruiting
720 enrolled
Breast

Triple Negative Breast Neoplasms

NCT04137653 2021-07-20

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Shengjing Hospital

Phase 3 Recruiting
1,498 enrolled
Breast

Breast Neoplasms

NCT01314833 2020-05-19

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Fudan University

Phase 3 Completed
1,570 enrolled
Breast

Primary Breast Cancer

NCT00689156 2018-04-05

READ

Danish Breast Cancer Cooperative Group

Phase 3 Completed
2,015 enrolled
Breast

Breast Neoplasms

NCT00912444 2016-11-22

NATT

Shanghai Jiao Tong University School of Medicine

Phase 3 Terminated
102 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡